Logo image of SALM.OL

SALMAR ASA (SALM.OL) Stock Fundamental Analysis

Europe - OSL:SALM - NO0010310956 - Common Stock

567.75 NOK
+9.25 (+1.66%)
Last: 11/4/2025, 3:49:16 PM
Fundamental Rating

4

Overall SALM gets a fundamental rating of 4 out of 10. We evaluated SALM against 58 industry peers in the Food Products industry. There are concerns on the financial health of SALM while its profitability can be described as average. SALM is valied quite expensively at the moment, while it does show a decent growth rate. SALM also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year SALM was profitable.
SALM had a positive operating cash flow in the past year.
SALM had positive earnings in each of the past 5 years.
In the past 5 years SALM always reported a positive cash flow from operatings.
SALM.OL Yearly Net Income VS EBIT VS OCF VS FCFSALM.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

With a Return On Assets value of 2.08%, SALM is not doing good in the industry: 63.79% of the companies in the same industry are doing better.
SALM has a Return On Equity (7.34%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 3.33%, SALM is doing worse than 65.52% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SALM is in line with the industry average of 7.46%.
Industry RankSector Rank
ROA 2.08%
ROE 7.34%
ROIC 3.33%
ROA(3y)5.59%
ROA(5y)7.01%
ROE(3y)16.59%
ROE(5y)17.93%
ROIC(3y)7.18%
ROIC(5y)7.81%
SALM.OL Yearly ROA, ROE, ROICSALM.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

SALM has a Profit Margin of 4.57%. This is comparable to the rest of the industry: SALM outperforms 53.45% of its industry peers.
SALM's Profit Margin has declined in the last couple of years.
SALM's Operating Margin of 10.66% is fine compared to the rest of the industry. SALM outperforms 68.97% of its industry peers.
In the last couple of years the Operating Margin of SALM has declined.
Looking at the Gross Margin, with a value of 49.66%, SALM is in the better half of the industry, outperforming 74.14% of the companies in the same industry.
SALM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.66%
PM (TTM) 4.57%
GM 49.66%
OM growth 3Y-4%
OM growth 5Y-3.92%
PM growth 3Y-13.56%
PM growth 5Y-11.19%
GM growth 3Y0.57%
GM growth 5Y-0.26%
SALM.OL Yearly Profit, Operating, Gross MarginsSALM.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SALM is destroying value.
SALM has about the same amout of shares outstanding than it did 1 year ago.
SALM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SALM is higher compared to a year ago.
SALM.OL Yearly Shares OutstandingSALM.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SALM.OL Yearly Total Debt VS Total AssetsSALM.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 2.04 indicates that SALM is not a great score, but indicates only limited risk for bankruptcy at the moment.
SALM has a Altman-Z score of 2.04. This is comparable to the rest of the industry: SALM outperforms 51.72% of its industry peers.
SALM has a Debt/Equity ratio of 1.26. This is a high value indicating a heavy dependency on external financing.
SALM has a Debt to Equity ratio of 1.26. This is in the lower half of the industry: SALM underperforms 79.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Altman-Z 2.04
ROIC/WACC0.43
WACC7.67%
SALM.OL Yearly LT Debt VS Equity VS FCFSALM.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

2.3 Liquidity

SALM has a Current Ratio of 1.75. This is a normal value and indicates that SALM is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SALM (1.75) is better than 70.69% of its industry peers.
SALM has a Quick Ratio of 1.75. This is a bad value and indicates that SALM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SALM (0.27) is worse than 94.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 0.27
SALM.OL Yearly Current Assets VS Current LiabilitesSALM.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

5

3. Growth

3.1 Past

SALM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.06%.
The Earnings Per Share has been decreasing by -0.01% on average over the past years.
Looking at the last year, SALM shows a decrease in Revenue. The Revenue has decreased by -9.03% in the last year.
The Revenue has been growing by 16.65% on average over the past years. This is quite good.
EPS 1Y (TTM)-38.06%
EPS 3Y7.44%
EPS 5Y-0.01%
EPS Q2Q%-69.71%
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y20.66%
Revenue growth 5Y16.65%
Sales Q2Q%5.77%

3.2 Future

Based on estimates for the next years, SALM will show a very strong growth in Earnings Per Share. The EPS will grow by 23.70% on average per year.
The Revenue is expected to grow by 11.39% on average over the next years. This is quite good.
EPS Next Y-27.79%
EPS Next 2Y24.86%
EPS Next 3Y23.7%
EPS Next 5YN/A
Revenue Next Year8.69%
Revenue Next 2Y12.79%
Revenue Next 3Y11.68%
Revenue Next 5Y11.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SALM.OL Yearly Revenue VS EstimatesSALM.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B 40B 50B
SALM.OL Yearly EPS VS EstimatesSALM.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10 20 30 40

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.40, which means the current valuation is very expensive for SALM.
Based on the Price/Earnings ratio, SALM is valued a bit more expensive than 72.41% of the companies in the same industry.
SALM is valuated rather expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 16.32, which indicates a correct valuation of SALM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SALM is on the same level as its industry peers.
SALM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.53.
Industry RankSector Rank
PE 39.4
Fwd PE 16.32
SALM.OL Price Earnings VS Forward Price EarningsSALM.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

77.59% of the companies in the same industry are cheaper than SALM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.3
SALM.OL Per share dataSALM.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

A more expensive valuation may be justified as SALM's earnings are expected to grow with 23.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.86%
EPS Next 3Y23.7%

7

5. Dividend

5.1 Amount

SALM has a Yearly Dividend Yield of 3.83%. Purely for dividend investing, there may be better candidates out there.
SALM's Dividend Yield is a higher than the industry average which is at 3.52.
Compared to an average S&P500 Dividend Yield of 2.38, SALM pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.83%

5.2 History

The dividend of SALM is nicely growing with an annual growth rate of 8.89%!
Dividend Growth(5Y)8.89%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

SALM pays out 7.41% of its income as dividend. This is a sustainable payout ratio.
The dividend of SALM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP7.41%
EPS Next 2Y24.86%
EPS Next 3Y23.7%
SALM.OL Yearly Income VS Free CF VS DividendSALM.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
SALM.OL Dividend Payout.SALM.OL Dividend Payout, showing the Payout Ratio.SALM.OL Dividend Payout.PayoutRetained Earnings

SALMAR ASA

OSL:SALM (11/4/2025, 3:49:16 PM)

567.75

+9.25 (+1.66%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-21 2025-08-21/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners75.73%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap76.87B
Revenue(TTM)25.40B
Net Income(TTM)1.16B
Analysts74.44
Price Target591.29 (4.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.83%
Yearly Dividend35.51
Dividend Growth(5Y)8.89%
DP7.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)29.34%
Min EPS beat(2)-46.06%
Max EPS beat(2)104.75%
EPS beat(4)2
Avg EPS beat(4)12.2%
Min EPS beat(4)-46.06%
Max EPS beat(4)104.75%
EPS beat(8)2
Avg EPS beat(8)-3.03%
EPS beat(12)3
Avg EPS beat(12)-15.4%
EPS beat(16)3
Avg EPS beat(16)-19.18%
Revenue beat(2)2
Avg Revenue beat(2)0.51%
Min Revenue beat(2)0.15%
Max Revenue beat(2)0.87%
Revenue beat(4)2
Avg Revenue beat(4)-0.86%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.87%
Revenue beat(8)4
Avg Revenue beat(8)-1.28%
Revenue beat(12)6
Avg Revenue beat(12)-0.13%
Revenue beat(16)9
Avg Revenue beat(16)0.69%
PT rev (1m)5.27%
PT rev (3m)7.86%
EPS NQ rev (1m)22.25%
EPS NQ rev (3m)-67.12%
EPS NY rev (1m)0%
EPS NY rev (3m)-53.75%
Revenue NQ rev (1m)3.72%
Revenue NQ rev (3m)-4.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.29%
Valuation
Industry RankSector Rank
PE 39.4
Fwd PE 16.32
P/S 3.03
P/FCF N/A
P/OCF 48.74
P/B 4.86
P/tB N/A
EV/EBITDA 21.3
EPS(TTM)14.41
EY2.54%
EPS(NY)34.78
Fwd EY6.13%
FCF(TTM)-7.21
FCFYN/A
OCF(TTM)11.65
OCFY2.05%
SpS187.62
BVpS116.74
TBVpS-35.87
PEG (NY)N/A
PEG (5Y)N/A
Graham Number194.55
Profitability
Industry RankSector Rank
ROA 2.08%
ROE 7.34%
ROCE 5.96%
ROIC 3.33%
ROICexc 3.36%
ROICexgc 6.23%
OM 10.66%
PM (TTM) 4.57%
GM 49.66%
FCFM N/A
ROA(3y)5.59%
ROA(5y)7.01%
ROE(3y)16.59%
ROE(5y)17.93%
ROIC(3y)7.18%
ROIC(5y)7.81%
ROICexc(3y)7.39%
ROICexc(5y)8.02%
ROICexgc(3y)13.13%
ROICexgc(5y)13.77%
ROCE(3y)12.87%
ROCE(5y)13.99%
ROICexgc growth 3Y-3.4%
ROICexgc growth 5Y-6.43%
ROICexc growth 3Y-7.07%
ROICexc growth 5Y-10.05%
OM growth 3Y-4%
OM growth 5Y-3.92%
PM growth 3Y-13.56%
PM growth 5Y-11.19%
GM growth 3Y0.57%
GM growth 5Y-0.26%
F-Score3
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.26
Debt/FCF N/A
Debt/EBITDA 4.37
Cap/Depr 137.11%
Cap/Sales 10.05%
Interest Coverage 1.98
Cash Conversion 34.52%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 0.27
Altman-Z 2.04
F-Score3
WACC7.67%
ROIC/WACC0.43
Cap/Depr(3y)181.78%
Cap/Depr(5y)256.7%
Cap/Sales(3y)10.1%
Cap/Sales(5y)14.83%
Profit Quality(3y)125.18%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.06%
EPS 3Y7.44%
EPS 5Y-0.01%
EPS Q2Q%-69.71%
EPS Next Y-27.79%
EPS Next 2Y24.86%
EPS Next 3Y23.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.03%
Revenue growth 3Y20.66%
Revenue growth 5Y16.65%
Sales Q2Q%5.77%
Revenue Next Year8.69%
Revenue Next 2Y12.79%
Revenue Next 3Y11.68%
Revenue Next 5Y11.39%
EBIT growth 1Y-59.9%
EBIT growth 3Y15.83%
EBIT growth 5Y12.08%
EBIT Next Year17.86%
EBIT Next 3Y28.69%
EBIT Next 5YN/A
FCF growth 1Y-120.62%
FCF growth 3Y59.94%
FCF growth 5Y10.72%
OCF growth 1Y-73.83%
OCF growth 3Y22.76%
OCF growth 5Y12.18%

SALMAR ASA / SALM.OL FAQ

Can you provide the ChartMill fundamental rating for SALMAR ASA?

ChartMill assigns a fundamental rating of 4 / 10 to SALM.OL.


What is the valuation status of SALMAR ASA (SALM.OL) stock?

ChartMill assigns a valuation rating of 2 / 10 to SALMAR ASA (SALM.OL). This can be considered as Overvalued.


Can you provide the profitability details for SALMAR ASA?

SALMAR ASA (SALM.OL) has a profitability rating of 4 / 10.


Can you provide the financial health for SALM stock?

The financial health rating of SALMAR ASA (SALM.OL) is 2 / 10.


Can you provide the expected EPS growth for SALM stock?

The Earnings per Share (EPS) of SALMAR ASA (SALM.OL) is expected to decline by -27.79% in the next year.